The Dermatology Digest

APRIL 3, 2024

Ligand Pharmaceuticals is launching Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and has appointed Scott Plesha as Chief Executive Officer to accelerate the commercialization of berdazimer topical gel, 10.3% (Zelsuvmi) for the treatment of molluscum contagiosum. Watch Now: Nanette B. in September 2023.

Pharmaceutical 36

Pharmaceutical Sales Office Partnerships 36

The Dermatology Digest

MAY 2, 2024

Aslan and Zenyaku are teaming up to explore how eblasakimab’s mechanism of action differs from that of other biologic therapies for atopic dermatitis (AD). This new agreement expands upon the commercial agreement that Aslan signed with Zenyaku in June 2023 for the development and commercialization of eblasakimab in Japan.

Pharmaceutical 74

Pharmaceutical Dermatitis Office Clinic 74

Hollywood Institute

JANUARY 2, 2023

Not only is this condition curable, but you aren’t restricted to opioids or other pharmaceutical treatments. Physical therapists incorporate pain management strategies like trigger point massages in their treatment routines because they successfully provide patients with pain relief. What is Trigger Point Therapy?

Therapy 52

Therapy Pharmaceutical Tools Irritation 52

The Dermatology Digest

MAY 15, 2024

Verrica Pharmaceuticals Inc. has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Torii) to jointly conduct a global pivotal Phase 3 clinical trial of YCANTH (cantharidin) for the treatment of common warts. With a prevalence of approximately 22 million patients in the U.S.

Pharmaceutical 36

Pharmaceutical Clinic Sales Dermatology 36

The Dermatology Digest

OCTOBER 26, 2024

Atopic dermatitis (AD) patients who switched to upadacitinib (Rinvoq, AbbVie) from dupilumab (Dupixent, Regeneron, and Sanofi) hit higher treatment targets, according to results from Period 2 of the LEVEL UP study. Both groups had similar proportions of patients with treatment-emergent adverse events (TEAEs).

Treatments 36

Treatments Dermatitis Pharmaceutical Eczema 36

The Dermatology Digest

MARCH 10, 2024

Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, discusses the need for a comprehensive treatment approach for CHE.

Treatments 36

Treatments Pharmaceutical Dermatitis Eczema 36

Aesthetics Advisor

FEBRUARY 11, 2024

Millions of people suffer for years or decades without treatment because insurance companies don’t approve screening for autoimmunity until the patient shows significant signs of organ or tissue destruction. At this point, the patient can be prescribed some type of immune-suppressing treatment.

Pharmaceutical 67

Pharmaceutical Diet Clinic Management 67

The Dermatology Digest

MARCH 11, 2024

Adding narrowband ultraviolet B phototherapy to treatment with ritlecitinib (Litfulo, Pfizer) in vitiligo may improve patient outcomes.

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

The Dermatology Digest

FEBRUARY 16, 2024

The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy.

Pharmaceutical 36

Pharmaceutical Safety Dermatitis Therapy 36

The Dermatology Digest

MARCH 10, 2024

Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, discusses the need for a comprehensive treatment approach for CHE. Topical isotretinoin, even when applied to 90% of a patient’s body surface area, showed minimal systemic absorption.

Treatments 36

Treatments Dermatitis Eczema Dermatology 36

The Dermatology Digest

MARCH 13, 2024

Adam Friedman, MD, Professor and Chair of Dermatology at George Washington School of Medicine and Health Sciences in Washington, DC, shares his excitement about chronic spontaneous urticaria (CSU) treatments coming down the pike including remibrutinib, Novartis’ investigational oral Bruton’s tyrosine kinase inhibitor.

Treatments 36

Treatments Dermatitis Dermatology Eczema 36

The Dermatology Digest

MAY 14, 2024

May is Ichthyosis Awareness Month, and TDD has curated its content on congenital ichthyosis (CI) to help raise awareness of the condition and shine a light on promising new therapies in the pipeline. Each year, more than 16,000 babies are born with some form of ichthyosis.

Pharmaceutical 36

Pharmaceutical Skin Types Dermatology Therapy 36

The Dermatology Digest

JULY 22, 2024

“Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. The post Biosimilar News: Stada, Alvotech Launch the First Ustekinumab Biosimilar Across Europe appeared first on The Dermatology Digest.

Partnerships 36

Partnerships Pharmaceutical Marketing Office 36

The Dermatology Digest

MARCH 13, 2024

Silverberg, MD, Chief of Pediatric Dermatology for the Mount Sinai Health System in New York, reviews the rationale for treating Molluscum Contagiosum and shares updates on available treatments including disruptive techniques and the newly approved Zelsuvmi (berdazimer topical gel, 10.3% (Zelsuvmi, Ligand) cantharidin (Ycanth, Verrica).

Treatments 28

Treatments Dermatitis Dermatology Eczema 28

Lipgloss and Aftershave

SEPTEMBER 3, 2024

One of the key goals for every medical + spa skin care professional is to find procedures, products, and devices that can be used in treatment to improve and correct skin issues. Over the past year, L+A has traveled the globe looking for the most effective treatment options to share with our community.

Chemical Peels 52

Chemical Peels Retinol Microneedling Skincare 52

The Dermatology Digest

OCTOBER 11, 2021

Hopefully in the future, we will be personalizing therapy selection based on clinical phenotypes or biomarkers. Stacking treatments to address multiple contributing mechanistic pathways rather than relying on a single agent will hopefully provide synergistic efficacy.” Thus, the search for biologic options to treat HS has continued.

Pharmaceutical 36

Pharmaceutical Clinic Treatments Consultation 36

The Beauty Brains

APRIL 1, 2019

On this episode we’re going to be answering your beauty questions about Thinning hair and the research going on in that area Whether cupping is an effective facial treatment Which sunscreen ingredients block UVA Why mandelic acid is used in deodorants. So, pharmaceutical companies are spending money researching this.

Pharmaceutical 52

Pharmaceutical Ingredients Facials Social Media 52

New Age Spa Institute

SEPTEMBER 28, 2023

Our esthetics, massage therapy, and make up students study the history of beauty culture through the ages. New Age Spa Institute recommends: Phytoboost – from the Coterie Fresh ‘N Clear line of pharmaceutical grade skincare prdocuts. It’s the natural oil with the highest amount of vitamin E Book a Galvanic Eye Treatment!

Skincare 52

Skincare Esthetics Esthetician Extractions 52

West Lake Dermatology

OCTOBER 15, 2024

GLP-1’s unique ability to affect both glucose metabolism and appetite makes it a critical hormone in weight management and a target for pharmaceutical treatments aimed at curbing hunger and improving metabolic health. Common side effects include nausea, vomiting, and diarrhea, particularly when starting treatment.

Medical 36

Medical Management Sustainability Pharmaceutical 36

Aesthetics Advisor

AUGUST 14, 2023

“If I see this presentation in someone on a statin medication, I will almost always assume the statin is at least a contributing factor and discuss with the patient its removal and replacement with another therapy.” Niacin is the most common and effective treatment that replaces statins, according to Dr. Smith. “Of

Document 36

Document Pharmaceutical Therapy Medical 36

Aesthetics Advisor

AUGUST 22, 2023

In this era of readily available pharmaceutical products for every imaginable ailment, it can be easy to default to the drug store when we need relief. Medieval Persian pharmaceutical manuscripts refer to 1200 types of oxymel. It has not always been that way. Reposted from: [link]

Extractions 36

Extractions Pharmaceutical Diet Ingredients 36

The Dermatology Digest

MARCH 11, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, discusses the need for a comprehensive treatment approach for CHE.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

The Dermatology Digest

MARCH 11, 2024

Jonathan Silverberg, MD, PhD, MPH, Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, discusses the need for a comprehensive treatment approach for CHE. Del Rosso, DO, a dermatologist in Las Vegas, NV, and the new President of the American Acne and Rosacea Society.

Dermatitis 36

Dermatitis Eczema Dermatology Pharmaceutical 36

New Age Spa Institute

JUNE 22, 2023

However, the connection between beauty culture and pharmaceutical interventions is one that demands critical examination. body treatments. From flawless skin to a slim figure, people find themselves going to extreme lengths to achieve the desired aesthetic of the moment. Chicago beauty school. tuition cost. beauty school education.

Esthetics 40

Esthetics Social Media Continuous Education Continuing Education 40

The Dermatology Digest

MARCH 13, 2024

Single-cell profiling of alopecia areata (AA) can provide key insights into immune-targeting treatment strategies. Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working. Watch Now Molluscum Contagiosum Treatment Update Nanette B. Silverberg, MD Nanette B.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 13, 2024

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, urges viewers to consider AD mimickers, especially when treatment isn’t working. Watch Now Molluscum Contagiosum Treatment Update Nanette B. Silverberg, MD Nanette B.

Dermatitis 36

Dermatitis Dermatology Clinic Skin Issues 36

The Dermatology Digest

MARCH 14, 2024

Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale University in New Haven, CT, shares some congenital ichthyosis (CI) cases and discusses the importance of understanding patient and family expectations about CI treatment.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 14, 2024

Chronic spontaneous urticaria (CSU) often has no identifiable trigger and is driven by mast cells, but symptoms are bothersome to patients, highlighting the need for effective treatments, says Jason Hawkes, MD, MS, a dermatologist in Rocklin, CA.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

The Dermatology Digest

MARCH 14, 2024

Watch Now Diagnosing AA: Making the Case for Single-cell Profiling Elizabeth Swanson, MD Single-cell profiling of alopecia areata (AA) can provide key insights into immune-targeting treatment strategies.

Dermatitis 36

Dermatitis Dermatology Clinic Eczema 36

Aesthetics Advisor

JANUARY 27, 2024

Use of medication with significant anticholinergic activity should likely be discouraged in older adults if alternative therapies are available,” Ms. Drugs not prescribed for psychoactive treatment have also been linked to dementia. She found that people taking anticholinergic drugs have greater shrinkage of overall brain volume.

Medical 36

Medical Pharmaceutical Marketing Therapy 36

The Dermatology Digest

MARCH 13, 2024

Watch Now Off-label Pearl: Exploring the Role of Narrowband UVB Phototherapy Plus Oral JAK Inhibitors in Vitiligo Emma Guttman-Yassky, MD, PhD Adding narrowband ultraviolet B phototherapy to treatment with ritlecitinib (Litfulo, Pfizer) in vitiligo may improve patient outcomes.

Dermatitis 28

Dermatitis Dermatology Eczema Clinic 28

Aesthetics Advisor

MARCH 15, 2024

Here’s a review of 10 natural antimicrobials you can reach for as a first line of defense, before resorting to a pharmaceutical antibiotic. Department of Health proposed guidelines recommending the use of honey as a first line of treatment for coughs, as part of its goal to reduce inappropriate antibiotic use. In 2018, the U.K.

Extractions 36

Extractions Medical Treatments Irritation 36

Aesthetics Advisor

JANUARY 29, 2024

percent reduction—on statin therapy. For such people, diet modification (increasing carbohydrates) rather than medications should be considered as the first line of treatment if LDL lowering is needed.” After the Oreo supplementation, it plummeted to 111 mg/dl, marking a 71 percent reduction. The study is meant to be a head-turner.

Management 36

Management Diet Medical Innovations 36

Aesthetics Advisor

JANUARY 22, 2024

As reported by the Consumer Wellness Center (CWC): 2 "The nonprofit Consumer Wellness Center has completed testing of eight popular bone broth and bone broth protein products to determine the possible presence of chemical pesticides, pharmaceuticals, industrial chemicals, toxicological chemicals and food additive chemicals.

Collagen 36

Collagen Vitamin C Diet Ingredients 36

Aesthetics Advisor

NOVEMBER 12, 2023

According to a 2011 study published in Current Pharmaceutical Design, with the help of fasting, it may offer protection against neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease ( 13 ). A 2007 study published in Nature has found that it may help the treatment of insulin resistance and diabetes ( 14 ).

Diet 36

Diet Training Pharmaceutical Therapy 36